Value-Based Contracting for Oncology Drugs: A NEHI White Paper

To download the full report, click here.

While new partnerships are developing between insurers and biopharmaceutical companies to increase patients’ access to medicines, outdated regulations prevent insurers from negotiating deals that lower the price of medicines when they are used in combinations or when they don’t deliver the promised benefits. This white paper from the Network for Excellence in Health Innovation (NEHI) outlines barriers to these outcomes-based contracts and highlights regulatory steps that would enable new payment arrangements for high-cost cancer treatments.